OPTASE- white petrolatum, lanolin ointment

Optase by

Drug Labeling and Warnings

Optase by is a Otc medication manufactured, distributed, or labeled by Scope Health Inc, Regulatory Matters Consulting. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Keep Out of Reach of Children

Purpose

Inactive Ingredients

Directions

Warnings

Uses

INSTRUCTIONS FOR USE

Instructions

Principal Display Panel

INGREDIENTS AND APPEARANCE

OPTASE 
white petrolatum, lanolin ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72972-003
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U)	PETROLATUM	0.9 g  in 1 g
LANOLIN (UNII: 7EV65EAW6H) (LANOLIN - UNII:7EV65EAW6H)	LANOLIN	0.06 g  in 1 g

Inactive Ingredients
Ingredient Name	Strength
LIGHT MINERAL OIL (UNII: N6K5787QVP)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72972-003-01	1 in 1 BOX	05/05/2021
1		5 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M018	05/05/2021

Labeler - Scope Health Inc (116778693)

Registrant - Regulatory Matters Consulting (080711165)